This state‐of‐the‐art review presents the latest evidence and the current status of
autogenous soft tissue grafting for soft tissue augmentation and recession coverage at teeth …

Aim: The use of recombinant human platelet-derived growth factor–BB (rhPDGF) has
received Food and Drug Administration approval for the treatment of periodontal and …

Background The aim of this systematic review was to assess the efficacy of three biologics,
namely autologous blood‐derived products (ABPs), enamel matrix derivatives (EMD) and …

Soft‐tissue dehiscence at the facial aspect of an osteointegrated implant is a common
complication which impacts on the final esthetic result. The etiology and ways of diagnosing …

Gingival recessions are vastly prevalent among the general population. With regards to their
treatment, recent advancements in periodontal and microsurgical procedures, focusing on …

This manuscript provides a state‐of‐the‐art review on the efficacy of biologics in root
coverage procedures, including enamel matrix derivative, platelet‐derived growth factor …

Gingival recession defect (GRD) may be defined as an apical migration of the gingival
margin respective to the cementoenamel junction resulting in partial exposure of the root …

Purpose Provide a comprehensive overview on the clinical use and the efficacy of growth
factors in different reconstructive procedures in the oral maxillofacial area. Materials and …

Abstract Background The efficacy of Coronally Advance Flap (CAF) has been extensively
evaluated and several parameters influencing the results, such as interproximal attachment …

The new classification of periodontal diseases recognizes the key role of the interdental
clinical attachment for defining the periodontal status and the extent of disease severity …